Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
Listen to from 49 mins left
https://twitter.com/wolf_financial/status/1599460048522342400?s=46&t=3OrYSRmZ6hk-tkmZaPwbqg
How do we get an invite to the shareholders meeting on 1st Dec 10.00 am?
Nothing on HL.
I got this from HL today. They had moved my shares out of my ISA.
Further to our previous correspondence, we have received confirmation from HMRC that the UK SPAC plc shares can remain within the ISA provided the reverse takeover currently underway progresses as planned. They have instructed us to review this matter periodically to ensure that, if the situation changes and it becomes necessary to remove the stock, we can act accordingly.
As a result of this confirmation, your UK SPAC plc shares will remain within your ISA
A very interesting thread from Eric Topol on the devastating effects of long Covid.
https://mobile.twitter.com/erictopol/status/1560460231112417280?s=21&t=XiOJ8QnwO3vNsdjGqOyhPg
My thoughts exactly Manifesto. Also the reduction in
Brain mass/ function could lead to an increase in people needing long term care. Think of the social and monitory cost of that in comparison to a few doses of SNG. Pardon the pun …A no brainer.
This u tube presentation from Dr John Campbell on the largest Long Covid study study published today is very interesting. Well worth a watch .
https://youtube.com/watch?v=F7x5LcUaUVQ&feature=share
Very interesting article from William A. Haseltine
Ex Harvard Prof.
In Forbes about BA 2.75
This is just a snippet
It’s Worth reading the whole article
Two of the unique mutations, S403L and P822S, lie in NSP3. This protein is involved in the formation of the structure of the double-membrane vesicle replication compartment. It also inhibits interferon activity by direct cleavage of IRF3 and antagonizing MDA5 activation. These mutations could therefore be involved in virus replication and immune evasion activities.
https://www.forbes.com/sites/williamhaseltine/2022/07/11/ba275-a-dark-horse-in-the-covid-pandemic/?sh=1b219f8b5985
Fingers crossed Air Jens future will be secured in the very near future. It’s been a difficult few months. I didn’t look at the board since the drop until recently.
Fingers crossed for the future. Hope all going well for you.
I agree trinity
I just think inhaled steroids while they work very efficiently are clunky with a degree of stepping up and down as per symptoms. Also dependant on the patient taking as required. If for example you could take inhaled Interferon say monthly as a preventative it would be a changer. We can but dream.
It’s time for a game changing drug in the respiratory field and SNG is it… There is no doubt in my mind that something more innovative then inhaled corticosteroids in the treatment of Asthma and COPD would be a game changer.
It may be due to the delisting
Just read about that below.
When I looked today at my holdings today on HL they are listed as N/A.
Has this happened to anyone else?
Overall, we think that our findings and identification of an immunoglobulin signature will help early identification of patients that are at increased risk of developing long Covid, which in turn will facilitate research, understanding and ultimately targeted treatments for long Covid,” said Onur Boyman, a professor of immunology who led the research.
The team studied 175 people who tested positive for Covid and 40 healthy volunteers who acted as a control group. To see how their symptoms changed over time, doctors followed 134 of the Covid patients for up to a year after their initial infection.
Blood tests on the participants showed that those who developed long Covid – also known as post-acute Covid-19 syndrome (Pacs) – tended to have low levels of the antibodies IgM and IgG3. When Covid strikes, IgM ramps up rapidly, while IgG antibodies rise later and provide longer-term protection.
This could be very good news for SNG….
Doctors have discovered an “antibody signature” that can help identify patients most at risk of developing long Covid, a condition where debilitating symptoms of the disease can persist for many months.
Researchers at University hospital Zurich analysed blood from Covid patients and found that low levels of certain antibodies were more common in those who developed long Covid than in patients who swiftly recovered.
Long Covid: nearly 2m days lost in NHS staff absences in England
When combined with the patient’s age, details of their Covid symptoms and whether or not they had asthma, the antibody signature allowed doctors to predict whether people had a moderate, high or very high risk of developing long-term illness.
Has to be this
https://m.youtube.com/watch?v=yrvGcCK0o_o